| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|---|
| 1. | MligTC455_24268 | 25 | 0.53 | Mlig455_005113, Mlig455_005115, Mlig455_005117, Mlig455_005192 | Neo: - |
CHRND | Mlig455_005113 {REF} {Length: 3205} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=111.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=60.6]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=132, Expect=2e-33]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=132, Expect=4e-34]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=129, Expect=2e-32]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=127, Expect=5e-32]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=127, Expect=1e-33]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=137, Expect=8e-36]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=135, Expect=2e-35]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=132, Expect=7e-34]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=133, Expect=1e-33]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=117, Expect=3e-29]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=124, Expect=4e-31]} {RNA1509_43533} {RNA1310_85291} {RNA815_51851} Mlig455_005115 {REF} {Length: 1135} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=22.3]} {RNA1509_43533} {RNA1310_20839.3} {RNA815_7971} Mlig455_005117 {REF} {Length: 1412} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=85.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=62.8]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=128, Expect=1e-31]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=124, Expect=1e-30]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=139, Expect=4e-36]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=126, Expect=1e-30]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=110, Expect=5e-26]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=112, Expect=2e-27]} {RNA1509_43533} {RNA1310_20839.3} {RNA815_7971} Mlig455_005192 {REF} {Length: 1376} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=83.4]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=62.8]} {Human: ENSG00000135902, CHRND, cholinergic receptor nicotinic delta subunit, [Score=125, Expect=2e-31]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=119, Expect=3e-29]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=131, Expect=6e-34]; ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=125, Expect=9e-32]} {Dmel: FBgn0028875, nAChRalpha5, nicotinic Acetylcholine Receptor alpha5, [Score=125, Expect=5e-31]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=110, Expect=9e-27]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [Score=111, Expect=6e-27]} {RNA1509_43533} {RNA1310_21349.3} {RNA815_7971} |